Results 151 to 160 of about 54,944 (282)

Clinical dilemma of mood stabilizer augmentation in treatment‐resistant schizophrenia with residual phase: A case report of valproate‐associated hypoglycemia and cytopenia, and subsequent lithium response

Psychiatry and Clinical Neurosciences Reports, Volume 5, Issue 2, June 2026.
Abstract Background Mood stabilizer augmentation is frequently used in treatment‐resistant schizophrenia despite limited guideline recommendations. Evidence for its efficacy and safety in the residual phase, however, remains insufficient. Case Presentation A 49‐year‐old Japanese woman with treatment‐resistant residual schizophrenia exhibited persistent
Yoshiki Kasagi, Naomichi Okamoto, Reiji Yoshimura   +2 more
wiley   +1 more source

Brivaracetam‐associated manic episode in a patient with bipolar disorder: A case report

Psychiatry and Clinical Neurosciences Reports, Volume 5, Issue 2, June 2026.
A patient with Bipolar I disorder developed manic symptoms following the initiation of brivaracetam for focal epilepsy. Although brivaracetam is generally considered to have favorable psychiatric tolerability, this case highlights a potential risk of mood destabilization in patients with underlying bipolar disorder.
Mihoko Kawai, Jun Miyata, Kousuke Kanemoto   +2 more
wiley   +1 more source

Blonanserin transdermal patch for treating delirium: A case series

Psychiatry and Clinical Neurosciences Reports, Volume 5, Issue 2, June 2026.
In a retrospective case series of 51 patients with delirium treated at a single center between 2020 and 2022, clinical improvement was observed in 84.3% of patients following the use of a blonanserin transdermal patch, often within 1–2 weeks. The patch was mainly selected for patients who had difficulty taking oral medications.
Mari Hemmi, Takuma Yamaguchi, Yuki Shigetsura, Daiki Hira, Hitoshi Tanimukai, Hirotsugu Kawashima, Yukiko Miyoshi, Hiroki Endo, Shunsaku Nakagawa, Tomohiro Terada   +9 more
wiley   +1 more source

Involuntary Clozapine Treatment: A Systematic Review

Acta Psychiatrica Scandinavica, Volume 153, Issue 6, Page 595-609, June 2026.
ABSTRACT Introduction We aimed to synthesize the information relevant for clinical practice on involuntary clozapine treatment. Methods Articles were identified with MEDLINE, Web of Sciences and PsycINFO search from inception through September 2025 (PROSPERO database registration CRD420251234475).
Hélène Verdoux, Alexis Lepetit, Peter F. J. Schulte   +2 more
wiley   +1 more source

Rare but relevant: Ibogaine and cardiovascular complications—prolonged QT interval and ventricular arrhythmias

Addiction, Volume 121, Issue 6, Page 1616-1621, June 2026.
Abstract Revived interest in psychedelic‐assisted therapies has also renewed focus on ibogaine, a psychoactive alkaloid, for its notable anti‐addictive potential. Evidence from observational, open‐label, and limited randomized placebo‐controlled trials indicates that ibogaine and its metabolite noribogaine reduce craving and withdrawal symptoms in ...
Tibor Markus Brunt
wiley   +1 more source

Critical Issues in the Management of Agitation, Aggression, and End-of-Life in Delusional Disorder: A Mini-Review. [PDF]

Healthcare (Basel), 2023
González-Rodríguez A, Seeman MV, Román E, Natividad M, Pagés C, Ghigliazza C, Ros L, Monreal JA.   +7 more
europepmc   +1 more source

The association between autism and psychosis and the tools used to measure it: An updated systematic review and meta‐analysis

British Journal of Clinical Psychology, Volume 65, Issue 2, Page 374-400, June 2026.
Abstract Objectives Autistic individuals are at increased risk of psychotic experiences and being diagnosed with psychotic disorders. This association may result from methodological issues, including the misinterpretation of psychosis questionnaires by autistic individuals and clinicians' difficulty distinguishing between the conditions.
Michael R. Miles, Dennis Golm, Emma Palmer‐Cooper   +2 more
wiley   +1 more source

Relationships between attachment insecurity, beliefs about the self and others, paranoia, and social functioning across the psychosis continuum

British Journal of Clinical Psychology, Volume 65, Issue 2, Page 530-550, June 2026.
Abstract Objectives Self‐beliefs and other‐regarding beliefs are related to attachment experiences and may contribute to paranoid beliefs and social functioning difficulties in psychosis. However, their relationships have not been examined jointly from an ecological perspective, while considering different degrees of psychosis risk.
Pilar de‐la‐Higuera‐Gonzalez, Carsten Allefeld, Alejandro de‐la‐Torre‐Luque, Ana Isabel Guillén, Marina Díaz‐Marsá, Anne‐Kathrin Fett   +5 more
wiley   +1 more source

Key Stakeholder Perspectives on Help‐Seeking for Psychosis in South and Southeast Asia: A Systematic Mixed‐Studies Review and Narrative Synthesis

International Journal of Mental Health Nursing, Volume 35, Issue 3, June 2026.
ABSTRACT Globally, in 2020, less than one‐third of individuals with psychosis accessed mental health services. These services are essential for reducing distress and burden, improving symptoms, and preventing adverse outcomes. However, people may not benefit from these services if they do not seek help.
Gading Ekapuja Aurizki, Robert Griffiths, Laoise Renwick   +2 more
wiley   +1 more source

Reversible Splenial Lesion Syndrome Due to Anti-NMDA Receptor Encephalitis Manifesting as Delusional Disorder: A Case Report and Literature Review. [PDF]

Brain Neurorehabil
Choi HB, Kim DH, Chang WH.
europepmc   +1 more source